Bearish
ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm is reminding investors of a class action lawsuit against Atara Biotherapeutics, Inc. (NASDAQ: ATRA) for alleged securities fraud. ...